14th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 8, 2019 |   |   |    | The Long and Winding Road Toward Molecular Cures of the First Molecular Disease John Tisdale, M.D. Senior Investigator Chief, Cellular and Molecular Therapeutics National Heart, Lung and Blood Institute https://videocast.nih.gov/launch.asp?28840  |  |   |  13th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 2, 2018 |   |    | Lightning Chess: How Host Immunity Gains a Winning Position Against Ebolavirus Infection Nancy Sullivan, PhD Senior Investigator Chief, Biodefense Research Section Vaccine Research Center National Institute of Allergy and Infectious Diseases https://videocast.nih.gov/launch.asp?26164  |  |   |  |   |  
 12th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 17, 2017  |    | CELLS AS ANTI-CANCER DRUGS: ENTERING MAINSTREAM ONCOLOGY Steven A. Rosenberg, M.D., Ph.D. Chief, Surgery Branch and Senior Investigator National Cancer Institute https://videocast.nih.gov/launch.asp?23596  |  |   |   |  |   |   |  11th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer October 14, 2016  |    | CYTOKINE SIGNALING: GENES, GENOMES AND DRUGS   John J. O'Shea, M.D.  Scientific Director and Senior Investigator  National Institute of Arthritis and Musculoskeletal and Skin Diseases    |  |   |   |  |   |   |  10th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer October 23, 2015  |    | UNEXPECTED RESULTS FROM UNCONVENTIONAL APPROACHES TO ADENO-ASSOCIATED VIRUS RESEARCH   Robert M. Kotin, Ph.D. Senior Investigator (1999–2014) at the National Heart, Lung and Blood Institute;  Vice President of Voyager Therapeutics (2014-2016);  Scientific Founder and Head of Discovery at Generation Bio, and Adjunct Professor at the Gene Therapy Center of the University of Massachusetts Medical School in Worcester    |  |   |   |  |   |   |  9th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer October 3, 2014  |    | PURINE RECEPTOR DRUGS: FUTURE TREATMENT FOR CHRONIC DISEASES?   Kenneth A. Jacobson, Ph.D. Chief, Laboratory of Bioorganic Chemistry & Molecular Recognition Section National Institute of Diabetes & Digestive & Kidney Diseases    |  |   |   |  |   |   |  8th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 22, 2013  |     | TB: IT TAKES MORE THAN A VILLAGE TO RAISE A REMEDY     Clifton E. Barry III, Ph.D. Chief, Tuberculosis Research Section National Institute of Allergy and Infectious Diseases   Carol A. Nacy, Ph.D. Co-Founder and CEO Sequella, Inc.    |  |   |   |  7th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 15, 2012  |    | A MULTIFUNCTIONAL BASEMENT MATRIX FOR NORMAL, CANCER, AND STEM CELLS: THE BME/MATRIGEL STORY    Hynda K. Kleinman, Ph.D. former Senior Investigator National Institute of Dental and Craniofacial Research    |  |   |   |  |   |   |  6th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer December 9, 2011  |    | TREATMENT OF CANCER WITH RECOMBINANT IMMUNOTOXINS: FROM TECHNOLOGY TRANSFER TO THE PATIENT   Ira Pastan, M.D. Co-Chief, Laboratory of Molecular Biology Head, Molecular Biology Section National Cancer Institute    |  |   |   |  |   |   |  5th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 5, 2010  |    | HUMAN RETROVIRUSES: PERSPECTIVES FROM THE PAST, PROSPECTS FOR THE FUTURE   Robert C. Gallo, M.D. The Homer & Martha Gudelsky Distinguished Professor in Medicine, and  Director, Institute of Human Virology  at the University of Maryland School of Medicine    |  |   |   |  |   |   |  4th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer November 13, 2009  |     | VIRAL HEPATITIS AND THE NIH: A JAUNDICED VIEW OF HISTORY   Harvey J. Alter, M.D. Chief, Infectious Disease Department of Transfusion Medicine NIH Clinical Center   Robert H. Purcell, M.D. Co-Chief, Laboratory of Infectious Diseases National Institute of Allergy and Infectious Diseases    |  |   |   |  |   |   |  3rd Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer September 18, 2008  |    | INNOVATION IN THE IMAGING SCIENCES AT THE NATIONAL INSTITUTES OF HEALTH   Robert S. Balaban, Ph.D. Director, Division of Intramural Research National Heart, Lung, and Blood Institute    |  |   |   |  |   |   |  2nd Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer January 26, 2007  |    | THE SCIENCE, TECHNOLOGY AND PROMISE OF PREVENTIVE HPV VACCINES    Douglas R. Lowy, M.D. Deputy Director, Center for Cancer Research Chief, Laboratory of Cellular Oncology National Cancer Institute    |  |   |   |  |   |   |  First Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer January 20, 2006  |    | INNOVATION AND COLLABORATION: REVOLUTIONIZING TB THERAPY   Maria Freire, Ph.D. CEO & President  Global Alliance for TB Drug Development     |  |   |   |  |   |   |  
          |